Key facts
- This page summarizes Heath Lukatch's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Jan 2023, 15:33.
Heath Lukatch - 10 Jan 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Reporting relationship
- Director
- Issuer ticker
- PCVX
- Reported as of
- 10 Jan 2023
- Net transaction value
- -$9,486
- SEC form
- 4
- Accepted by SEC
- 12 Jan 2023, 15:33:18 UTC
- Prior SEC filing
- 14 Dec 2022
- Next SEC filing
- 08 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- Heath Lukatch, by /s/ Ron A. Metzger, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Heath Lukatch filed Form 4 for Vaxcyte, Inc. (PCVX) on 12 Jan 2023.
Change
- Previous filing in this sequence was filed on 14 Dec 2022.
- Current net transaction value: -$9,486.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCVX
transaction
Common Stock
Options Exercise
- Transaction value
- $5,040
- Shares
- +315
- Change %
- +10%
- Price
- $16.00
- Shares after
- 3,440
- Date
- 10 Jan 2023
- Ownership
- Direct
PCVX
transaction
Common Stock
Sale
- Transaction value
- $10,728
- Shares
- -233
- Change %
- -6.8%
- Price
- $46.04
- Shares after
- 3,207
- Date
- 10 Jan 2023
- Ownership
- Direct
- Footnotes
- F1, F2
PCVX
transaction
Common Stock
Sale
- Transaction value
- $3,799
- Shares
- -82
- Change %
- -2.6%
- Price
- $46.33
- Shares after
- 3,125
- Date
- 10 Jan 2023
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCVX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -315
- Change %
- -1.1%
- Price
- $0.000000
- Shares after
- 28,000
- Date
- 10 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 315
- Exercise price
- $16.00
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Footnote F2
The price reported is a weighted-average price. The shares were sold at prices ranging from $45.27 to $46.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
The price reported is a weighted-average price. The shares were sold at prices ranging from $46.29 to $46.385. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F4
1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter.